Navigation Links
BIDMC researchers named among 'the most influential scientific minds'
Date:8/21/2014

BOSTON -- Nine researchers from Beth Israel Deaconess Medical Center (BIDMC ) are among the investigators included in "The World's Most Influential Scientific Minds 2014," a comprehensive list compiled by analysts from Thomson Reuters ScienceWatch, a web resource for science metrics and research performance analysis.

The scientists recognized as among the most influential "are performing and publishing work that their peers recognized as vital to the advancement of their science," according to a Thomson Reuters statement. Researchers were identified based on the number of highly cited papers produced during an 11-year period from 2002 to 2012.

BIDMC investigators named on the "Influential Scientific Minds" list include Donald E. Cutlip, MD, CardioVascular Institute; Michael D. Fox, MD, PhD, Department of Neurology; C. Michael Gibson, MD, PhD, CardioVascular Institute; Sharon K. Inouye, MD, MPH, Division of Gerontology; Bruce E. Landon, MD, MBA, Department of Medicine; Jeffrey J. Popma, MD, CardioVascular Institute; Clifford B. Saper, MD, PhD, Department of Neurology; Michael S. Seaman, PhD, Center for Virology and Vaccine Research; and Larry J. Seidman, PhD, Department of Psychiatry.

Inclusion in the list is based on the number of "highly cited" papers that each of the researchers has published in his or her field. Scientific citations refer to the number of times that researchers have been acknowledged, or "cited" by other scientists as having inspired or guided their own research.

"This type of recognition carries enormous weight," said BIDMC's Chief Academic Officer Vikas P. Sukhatme, MD, PhD. "Such an objective analysis indicates the tremendous value of an investigator's work to his or her own field and, more broadly, to biomedical research and the advancement of medical discoveries. We are proud to have investigators representing a wide range of BIDMC's research included in this analysis. Their inclusion is a reflection of the widespread influence that BIDMC research plays in categories that include clinical medicine as well as microbiology, neuroscience, psychiatry and social sciences."

The BIDMC investigators included in the listing of Highly Cited Researchers include:

Donald E. Cutlip, MD, is Section Chief of Interventional Cardiology in BIDMC's CardioVascular Institute. His work addressing stent thrombosis was one of Thomson Reuters' most highly cited papers, providing a standardized method to design and report results evaluating the clinical trials of coronary stents.

Michael D. Fox, MD, PhD, is the Director of the Laboratory for Brain Network Imaging and Modulation in the Department of Neurology. His research focuses on the development of new and improved treatments for neuropsychiatric diseased based on understanding brain networks and the effects of brain stimulation.

C. Michael Gibson, MD, PhD, is an interventional cardiologist who pioneered our understanding of the open artery hypothesis as well the importance of restoring flow downstream in the capillary bed in the "open microvasculature hypothesis" in cases of heart attack. He has invented measures of coronary blood widely used today (TIMI frame count, TIMI myocardial perfusion grade.)

Sharon K. Inouye, MD, MPH, is a member of the Division of Gerontology at BIDMC and Director of the Aging Brain Center in the Institute for Aging Research at Hebrew SeniorLife. Her clinical investigations focus on the diagnosis, risk factors, prevention and outcomes of delirium in elderly patients and the interface of delirium and dementia.

Bruce E. Landon, MD, MBA, is a member of the Department of Medicine at BIDMC and his research focuses on the organization and financing of health care and its relationship to the costs and outcomes of care.

Jeffrey J. Popma, MD, is Director of Interventional Cardiology Clinical Services at BIDMC. His research focuses on the angiographic evaluation of new technology and transcatheter aortic valve replacement. His group has served as the core laboratory for numerous new technologies including those for carotid and coronary applications.

Clifford B. Saper, MD, PhD, Chairman of Neurology at BIDMC, studies the brain circuitry that controls basic functions, including sleep-wake cycles and circadian rhythms, as well as cardiovascular and respiratory function, identifying the brain's sleep-promoting systems as well as brainstem circuitry controlling autonomic and respiratory activity.

Michael S. Seaman, PhD, is an investigator in the Center for Virology and Vaccine Research where his work focuses on the development of a vaccine against HIV-1/AIDS. He conducts both basic research in the laboratory setting and is testing candidate vaccines in human clinical trials.

Larry J. Seidman, PhD, of BIDMC's Department of Psychiatry and Director of the Commonwealth Research Center, studies cognition, brain function and structure and their treatment in youth at risk for psychotic disorders, especially schizophrenia, focusing on development of early intervention and prevention strategies.


'/>"/>

Contact: Bonnie Prescott
bprescot@bidmc.harvard.edu
617-667-7306
Beth Israel Deaconess Medical Center
Source:Eurekalert

Related biology news :

1. BIDMC cardiovascular institute researchers will lead $4 million NIH grant to study micrornas
2. Study by UC Santa Barbara researchers suggests that bacteria communicate by touch
3. UC Santa Barbara researchers discover genetic link between visual pathways of hydras and humans
4. Researchers attempt to solve problems of antibiotic resistance and bee deaths in one
5. UNH researchers find African farmers need better climate change data to improve farming practices
6. Ottawa researchers to lead world-first clinical trial of stem cell therapy for septic shock
7. Researchers uncover molecular pathway through which common yeast becomes fungal pathogen
8. Researchers print live cells with a standard inkjet printer
9. Columbia Engineering and Penn researchers increase speed of single-molecule measurements
10. Researchers reveal how a single gene mutation leads to uncontrolled obesity
11. Researchers discover novel therapy for Crohns disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... , April 28, 2016 First quarter ... (139.9), up 966% compared with the first quarter of 2015 ... totaled SEK 589.1 M (loss: 18.8) and the operating margin was ... (loss: 0.32) Cash flow from operations was SEK 249.9 ... 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. The ...
(Date:4/26/2016)... , April 27, 2016 ... "Global Multi-modal Biometrics Market 2016-2020"  report to their ... , The analysts forecast the global ... of 15.49% during the period 2016-2020.  ... of sectors such as the healthcare, BFSI, transportation, ...
(Date:4/15/2016)... 2016  A new partnership announced today will ... decisions in a fraction of the time it ... high-value life insurance policies to consumers without requiring ... Force Diagnostics, rapid testing (A1C, Cotinine and HIV) ... pressure, weight, pulse, BMI, and activity data) available ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge (BDC), ... new ways to harness living systems and biotechnology, announced ... (MoMA) in New York City . ... participating students, showcased projects at MoMA,s Celeste Bartos Theater ... Antonelli , MoMA,s senior curator of architecture and design, ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... In a ... Hospital in Denmark detail how a patient who developed lymphedema after being treated for ... The results could change the paradigm for dealing with this debilitating, frequent side effect ...
(Date:6/23/2016)... June 23, 2016 On Wednesday, June ... 4,833.32, down 0.22%; the Dow Jones Industrial Average edged 0.27% ... at 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage on the ... Nektar Therapeutics (NASDAQ: NKTR ), Aralez Pharmaceuticals Inc. ... BIND ). Learn more about these stocks by ...
(Date:6/23/2016)... June 22, 2016  Amgen (NASDAQ: AMGN ... QB3@953 life sciences incubator to accelerate the ... shared laboratory space at QB3@953 was created to help ... obstacle for many early stage organizations - access to ... sponsorship, Amgen launched two "Amgen Golden Ticket" awards, providing ...
Breaking Biology Technology: